Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MDEV vs RSPH overlap: 19% of top holdings shared

Bottom line

How much do MDEV and RSPH overlap?

19% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 11.3% of MDEV's assets and 9.0% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

MDEVRSPH
Weight overlap (top 25)19%
Shared holdings5
Weight in shared holdings11.3%9.0%
Total positions5163
Expense ratio0.7%0.4%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings MDEV and RSPH have in common

Holding% of MDEV% of RSPHOverlap
Baxter International Inc BAX2.55%1.99%1.99%
Revvity Inc RVTY2.54%1.72%1.72%
Dexcom Inc DXCM2.16%1.73%1.73%
Thermo Fisher Scientific Inc TMO2.06%1.84%1.84%
Becton Dickinson & Company BDX2.01%1.73%1.73%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MDEV

  1. West Pharmaceutical Services Inc — 2.86%
  2. Demant A/s — 2.70%
  3. Livanova Plc — 2.69%
  4. Straumann Holding Ag — 2.53%
  5. Wuxi Apptec Co Ltd — 2.44%
  6. Waters Corp — 2.40%
  7. Edwards Lifesciences Corp — 2.38%
  8. Agilent Technologies Inc — 2.37%
  9. Olympus Corp — 2.20%
  10. Teleflex Inc — 2.19%
  11. Bio-rad Laboratories Inc — 2.16%
  12. Sysmex Corp — 2.14%
  13. Sartorius Stedim Biotech Sa — 2.13%
  14. Terumo Corp — 2.12%
  15. Sonova Holding Ag — 2.11%

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Regeneron Pharmaceuticals, Inc. — 1.96%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Charles River Laboratories International, Inc. — 1.93%
  6. Veeva Systems Inc. — 1.93%
  7. DaVita Inc. — 1.87%
  8. Moderna, Inc. — 1.85%
  9. Abbott Laboratories — 1.83%
  10. Bristol-Myers Squibb Co. — 1.82%
  11. Universal Health Services, Inc. — 1.80%
  12. Labcorp Holdings Inc. — 1.78%
  13. Quest Diagnostics Inc. — 1.77%
  14. Amgen Inc. — 1.77%
  15. Incyte Corp. — 1.76%

Asset mix

Asset typeMDEVRSPH
Stocks99.5%99.9%
Cash & short-term funds0.5%2.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryMDEVRSPH
US55.8%98.9%
JP8.1%—
CH6.4%—
GB4.5%—
DK4.4%—
CN4.1%—
DE3.9%—
IE3.8%3.4%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do MDEV and RSPH overlap?
About 19% by weight. 5 securities appear in both funds' top 25 holdings; they make up 11.3% of MDEV's assets and 9.0% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do MDEV and RSPH have in common?
The largest shared holdings are Baxter International Inc, Thermo Fisher Scientific Inc, Becton Dickinson & Company, Dexcom Inc, Revvity Inc.
Should I own both MDEV and RSPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, MDEV or RSPH?
RSPH is broader, with 63 positions versus 51 for MDEV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.